Bulk Manufacturer of Controlled Substances Application: Irvine Labs Inc., 57131 [2023-17984]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 161 / Tuesday, August 22, 2023 / Notices
ACTION:
Notice of application.
DEPARTMENT OF JUSTICE
Pisgah Laboratories Inc. has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
Drug Enforcement Administration
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 23, 2023. Such
persons may also file a written request
for a hearing on the application on or
before October 23, 2023.
AGENCY:
SUMMARY:
DATES:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 10, 2023, Pisgah
Laboratories Inc, 3222 Old
Hendersonville Highway, Pisgah Forest,
North Carolina 28768, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
lotter on DSK11XQN23PROD with NOTICES1
Ibogaine ........................
Tapentadol ....................
Drug
code
Schedule
7260
9780
I
II
The company plans to bulk
manufacture the above-listed controlled
substances in bulk for internal research
purposes and distribution to its
customers. No other activities for these
drug codes are authorized for this
registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–17971 Filed 8–21–23; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
16:57 Aug 21, 2023
Jkt 259001
[Docket No. DEA–1249]
Bulk Manufacturer of Controlled
Substances Application: Irvine Labs
Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
Irvine Labs Inc. has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 23, 2023. Such
persons may also file a written request
for a hearing on the application on or
before October 23, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on July 10, 2023, Irvine
Labs Inc., 7305 Murdy Circle,
Huntington Beach, California 92647–
3533, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Drug
code
Diethyltryptamine ....................
Dimethyltryptamine .................
Lysergic acid diethylamide .....
Mescaline ................................
Peyote .....................................
Psilocybin ................................
Psilocyn ...................................
7434
7435
7315
7381
7415
7437
7438
Schedule
I
I
I
I
I
I
I
The company plans to bulk
manufacture the above listed controlled
substances for research and
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
development purposes internally and
for distribution to its research
customers. No other activities for these
drug codes are authorized for this
registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–17984 Filed 8–21–23; 8:45 am]
BILLING CODE P
SUMMARY:
Controlled substance
57131
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1247]
Bulk Manufacturer of Controlled
Substances Application: Cambrex
Charles City
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cambrex Charles City has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 23, 2023. Such
persons may also file a written request
for a hearing on the application on or
before October 23, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on July 3, 2023, Cambrex
Charles City, 1205 11th Street, Charles
City, Iowa 50616–3466, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUMMARY:
E:\FR\FM\22AUN1.SGM
22AUN1
]]>Agencies
[Federal Register Volume 88, Number 161 (Tuesday, August 22, 2023)]
[Notices]
[Page 57131]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17984]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1249]
Bulk Manufacturer of Controlled Substances Application: Irvine
Labs Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Irvine Labs Inc. has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
October 23, 2023. Such persons may also file a written request for a
hearing on the application on or before October 23, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on July 10, 2023, Irvine Labs Inc., 7305 Murdy Circle,
Huntington Beach, California 92647-3533, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Diethyltryptamine...................... 7434 I
Dimethyltryptamine..................... 7435 I
Lysergic acid diethylamide............. 7315 I
Mescaline.............................. 7381 I
Peyote................................. 7415 I
Psilocybin............................. 7437 I
Psilocyn............................... 7438 I
------------------------------------------------------------------------
The company plans to bulk manufacture the above listed controlled
substances for research and development purposes internally and for
distribution to its research customers. No other activities for these
drug codes are authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-17984 Filed 8-21-23; 8:45 am]
BILLING CODE P
